Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Joon Ho Sa"'
Autor:
Hye Young Han, Jung A Lee, Hyeung-geun Park, Young Ah Shin, Shinae Kim, Jewon Yang, Jung Eun Lee, Yong Hyuk Kim, Joon Ho Sa, Hyun Joo Son, Jeeyeon Lee, Jae-Sun Kim, Je Ho Ryu
Publikováno v:
Journal of Medicinal Chemistry. 59:10176-10189
A series of picolinamide- and pyrimidine-4-carboxamide-based inhibitors of 11β-hydroxysteroid dehydrogenase type 1 was synthesized and evaluated to optimize the lead compound 9. The combination of the replacement of a pyridine ring of 9 with a pyrim
Autor:
Je Ho, Ryu, Jung A, Lee, Shinae, Kim, Young Ah, Shin, Jewon, Yang, Hye Young, Han, Hyun Joo, Son, Yong Hyuk, Kim, Joon Ho, Sa, Jae-Sun, Kim, Jungeun, Lee, Jeeyeon, Lee, Hyeung-Geun, Park
Publikováno v:
Journal of medicinal chemistry. 59(22)
A series of picolinamide- and pyrimidine-4-carboxamide-based inhibitors of 11β-hydroxysteroid dehydrogenase type 1 was synthesized and evaluated to optimize the lead compound 9. The combination of the replacement of a pyridine ring of 9 with a pyrim
Autor:
Chang-Ik Choi, Seok-Yong Lee, Young Seo Park, Mi-Jeong Kim, Chang-Seon Myung, Jung-Woo Bae, Joon-Ho Sa, Yee Song, Choon-Gon Jang
Publikováno v:
Journal of Liquid Chromatography & Related Technologies. 31:2455-2466
This study was aimed to validate a reliable analytical method for the pharmacokinetic study of amiloride in human plasma by a high performance liquid chromatography (HPLC) system with UV detection. Triamterene was used as an internal standard. After
Autor:
Su Sung Kim, Hyun Jung Lee, Joon Ho Sa, Kyeong-Hoon Jeong, Hyun Joo Son, Cheol Soo Choi, Hye Young Han, Shinae Kim, Hyunhee Oh, Hee-Sook Jun, Je Ho Ryu
Publikováno v:
European journal of pharmacology. 768
11β-Hydroxysteroid dehydrogenase type 1 (11βHSD1) has been targeted for new drugs to treat type 2 diabetes and metabolic syndrome. In this study, we determined whether the inhibition of 11βHSD1 with a new selective inhibitor, SKI2852, could improv
Autor:
Seok-Yong Lee, Yun-Jeong Lee, Jung-Woo Bae, Hye-In Lee, Choon-Gon Jang, Chang-Ik Choi, Joon-Ho Sa
Publikováno v:
International journal of clinical pharmacology and therapeutics. 52(11)
Objective Pitavastatin, a highly potent inhibitor of 3-hydroxy-methylglutarylcoenzyme A reductase, is a known substrate of OATP1B1. Ursodeoxycholic acid (UDCA) inhibits OATP1B1 expression by repressing hepatocyte nuclear factor 1α (HNF1α). Thus, th